A Phase 2 randomized proff of concept study of Nab-Paclitaxel/Gemcitabine alone and in combination with ACP-196 in subjects with previously untreated metastatic pancreatic cancer.
Clinical Trial Grant
Administered By
Duke Cancer Institute
Awarded By
Acerta Pharma
Start Date
November 1, 2015
End Date
October 19, 2017
Administered By
Duke Cancer Institute
Awarded By
Acerta Pharma
Start Date
November 1, 2015
End Date
October 19, 2017